Warburg Pincus mulls $5bn-plus ModMed sale
Warburg Pincus is exploring strategic options for its portfolio company Modernizing Medicine, which could include a sale in a deal valued at over $5bn, including debt, according to a report by Reuters citing unnamed sources familiar with the matter.
